✦ LIBER ✦

High incidence of chronic graft-versus-host disease after myeloablative allogeneic stem cell transplantation for chronic lymphocytic leukemia in Sweden: graft-versus-leukemia effect protects against relapse

✍ Scribed by Machaczka, Maciej; Johansson, Jan-Erik; Remberger, Mats; Hallböök, Helene; Lazarevic, Vladimir Lj; Wahlin, Björn Engelbrekt; Omar, Hamdy; Wahlin, Anders; Juliusson, Gunnar; Kimby, Eva; Hägglund, Hans

Book ID: 121599389
Publisher: Springer US
Year: 2013
Tongue: English
Weight: 328 KB
Volume: 30
Category: Article
ISSN: 1357-0560
DOI: 10.1007/s12032-013-0762-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Does Extra Alemtuzumab Remove the Graft-

Does Extra Alemtuzumab Remove the Graft-versus-Leukemia Effect after Allogeneic Stem Cell Transplantation in Chronic Lymphocytic Leukemia?

✍ Bipin N. Savani; Stacey Goodman; Nishitha Reddy 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 95 KB

Immune Biology of Allogeneic Hematopoiet

Immune Biology of Allogeneic Hematopoietic Stem Cell Transplantation || B and T cells in chronic graft-versus-host disease and graft-versus-leukemia

✍ Jacobson, Caron A. 📂 Article 📅 2013 🏛 Elsevier ⚖ 664 KB

Allogeneic Stem Cell Transplantation in

Allogeneic Stem Cell Transplantation in First Complete Remission Enhances Graft-versus-Leukemia Effect in Adults with Acute Lymphoblastic Leukemia: Antileukemic Activity of Chronic Graft-versus-Host Disease

✍ Seok Lee; Byung-Sik Cho; Sung-Yong Kim; Su-Mi Choi; Dong-Gun Lee; Ki-Seong Eom; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 495 KB

The graft-versus-leukemia effect is main

The graft-versus-leukemia effect is mainly restricted to NIH-defined chronic graft-versus-host disease after reduced intensity conditioning before allogeneic stem cell transplantation

✍ Thepot, S; Zhou, J; Perrot, A; Robin, M; Xhaard, A; de Latour, R P; Ades, L; Rib 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 338 KB

Association With the Presence of Naive T

Association With the Presence of Naive T Cells in Chronic Myeloid Leukemia Patients After Allogeneic Human Stem Cell Transplantation and the Lower Incidence of Chronic Graft-Versus Host Disease and Relapse

✍ B. Wysoczanska; K. Bogunia-Kubik; D. Dlubek; E. Jaskula; A. Sok; D. Drabczak-Skr 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 195 KB

Minimal residual disease is common after

Minimal residual disease is common after allogeneic stem cell transplantation in patients with B cell chronic lymphocytic leukemia and may be controlled by graft-versus-host disease

✍ Mattsson, J; Uzunel, M; Remberger, M; Ljungman, P; Kimby, E; Ringdén, O; Zetterq 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 167 KB